BASF Navigates Cost-Cutting Amidst Cautious Market Outlook

The world’s largest chemical company has painted a clear, if mixed, picture of its current position. While a determined restructuring plan is underway, the firm’s forward guidance has fallen short of market expectations. This raises a critical question: can the extensive savings program sufficiently counterbalance the underlying structural pressures the company faces?

A Measured Path Forward with Shareholder Returns Intact

In a clear signal to investors, BASF remains committed to its capital return policy. The company executed share repurchases exceeding 3.5 million shares in the first week of March alone. This activity is part of an ongoing buyback initiative valued at up to €1.5 billion, scheduled for completion by the end of June. Furthermore, this program is embedded within a broader €4 billion framework announced at the 2024 Capital Markets Day, extending through 2028. All repurchased shares are being retired, leading to a corresponding reduction in share capital.

The dividend policy also remains unchanged. The board has proposed a payout of €2.25 per share, with an ex-dividend date set for May 4, 2026. This commitment persists despite the fact that the 2025 free cash flow of €1.34 billion did not fully cover the dividend payout on a purely mathematical basis. Overall, BASF is targeting aggregate capital returns of at least €12 billion between 2025 and 2028.

Ambitious Savings Goals Contrast with Subdued Earnings Forecast

The near-term operational outlook, however, is more sobering. For the 2026 fiscal year, BASF anticipates EBITDA before special items in a range of €6.2 to €7.0 billion. The midpoint of this guidance, €6.6 billion, sits notably below the analyst consensus estimate of approximately €7.0 billion. An additional headwind looms in the first quarter, where currency effects from a weaker US dollar alone could negatively impact earnings by up to €200 million.

Should investors sell immediately? Or is it worth buying BASF?

CEO Markus Kamieth does not foresee a near-term economic rebound or a easing of geopolitical tensions. He projects a tangible recovery is unlikely before late 2026, with a more realistic timeline pointing to 2027.

Against this challenging backdrop, the restructuring program is advancing. Annualized cost savings reached €1.7 billion by the end of 2025, with the target set at €2.3 billion by the close of 2026. Since the end of 2023, 4,800 positions have been eliminated, with further reductions planned in administration and IT functions. Concurrently, capital expenditure for the 2026-2029 period has been slashed by 20% to €13 billion. The company is also divesting non-core operations; the optical brighteners business has already been sold, and the coatings division is slated to follow in the second quarter.

On the product innovation front, BASF is leveraging sustainability as a key differentiator. Its Intermediates division has launched new, lower-carbon versions of essential chemicals—including butanediol and the solvent NMP—featuring a CO₂ footprint reduced by a minimum of 10%. These products are manufactured at the Ludwigshafen site.

Trading approximately 13% below its 52-week high, the share price symbolically reflects the company’s current state: a solid foundation is in place, but a clear catalyst for upward momentum is not yet visible. When shareholders convene at the Annual Meeting in Mannheim on April 30, the central debate will likely focus on whether the current strategic course can yield results swiftly enough.